Jefferies Financial Group Inc. Has $7.20 Million Stock Holdings in McKesson Co. (NYSE:MCK)

Jefferies Financial Group Inc. increased its position in shares of McKesson Co. (NYSE:MCK - Free Report) by 48.6% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 12,626 shares of the company's stock after purchasing an additional 4,131 shares during the period. Jefferies Financial Group Inc.'s holdings in McKesson were worth $7,196,000 at the end of the most recent reporting period.

Other large investors have also recently bought and sold shares of the company. Capital A Wealth Management LLC bought a new stake in McKesson in the fourth quarter valued at $26,000. Millstone Evans Group LLC bought a new stake in McKesson in the fourth quarter valued at $28,000. Synergy Asset Management LLC bought a new stake in shares of McKesson during the fourth quarter worth $32,000. Crews Bank & Trust bought a new stake in shares of McKesson during the fourth quarter worth $33,000. Finally, Atala Financial Inc bought a new stake in shares of McKesson during the fourth quarter worth $34,000. 85.07% of the stock is currently owned by institutional investors.

Insider Buying and Selling at McKesson

In other news, CAO Napoleon B. Rutledge, Jr. sold 543 shares of McKesson stock in a transaction dated Monday, May 19th. The stock was sold at an average price of $726.51, for a total transaction of $394,494.93. Following the transaction, the chief accounting officer now owns 1,972 shares in the company, valued at $1,432,677.72. The trade was a 21.59% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CFO Britt J. Vitalone sold 6,336 shares of McKesson stock in a transaction dated Thursday, May 22nd. The shares were sold at an average price of $717.30, for a total value of $4,544,812.80. Following the transaction, the chief financial officer now owns 14,760 shares in the company, valued at $10,587,348. This trade represents a 30.03% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 10,856 shares of company stock valued at $7,793,675. 0.11% of the stock is currently owned by company insiders.

McKesson Trading Up 1.0%

Shares of MCK traded up $6.99 during trading hours on Friday, hitting $719.85. 1,322,227 shares of the stock traded hands, compared to its average volume of 917,774. McKesson Co. has a 1-year low of $464.42 and a 1-year high of $731.00. The business has a fifty day moving average of $695.18 and a 200-day moving average of $637.67. The firm has a market capitalization of $90.06 billion, a PE ratio of 32.96, a price-to-earnings-growth ratio of 1.29 and a beta of 0.53.

McKesson (NYSE:MCK - Get Free Report) last released its earnings results on Thursday, May 8th. The company reported $10.12 earnings per share for the quarter, beating the consensus estimate of $9.83 by $0.29. McKesson had a negative return on equity of 181.26% and a net margin of 0.82%. The firm had revenue of $90.82 billion for the quarter, compared to analyst estimates of $94 billion. During the same quarter in the prior year, the firm posted $6.18 earnings per share. The company's quarterly revenue was up 18.9% on a year-over-year basis. As a group, equities research analysts expect that McKesson Co. will post 32.77 earnings per share for the current fiscal year.

McKesson Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, July 1st. Shareholders of record on Monday, June 2nd will be paid a $0.71 dividend. This represents a $2.84 annualized dividend and a yield of 0.39%. The ex-dividend date is Monday, June 2nd. McKesson's payout ratio is 10.99%.

Analyst Ratings Changes

Several brokerages have recently commented on MCK. Wells Fargo & Company increased their target price on McKesson from $641.00 to $691.00 and gave the stock an "equal weight" rating in a report on Friday, March 14th. Morgan Stanley increased their target price on McKesson from $642.00 to $745.00 and gave the stock an "overweight" rating in a report on Wednesday, April 2nd. Evercore ISI increased their target price on McKesson from $650.00 to $675.00 and gave the stock an "outperform" rating in a report on Thursday, February 6th. Bank of America increased their target price on McKesson from $755.00 to $800.00 and gave the stock a "buy" rating in a report on Friday, May 9th. Finally, Cfra Research cut McKesson from a "moderate buy" rating to a "hold" rating in a report on Friday, April 4th. Three research analysts have rated the stock with a hold rating, eleven have given a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat.com, McKesson has a consensus rating of "Moderate Buy" and a consensus target price of $686.69.

McKesson Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.